LEVOXYL Drug Patent Profile

When do Levoxyl patents expire, and when can generic versions of Levoxyl launch?

Levoxyl is a drug marketed by King Pharms and is included in one NDA.

The generic ingredient in LEVOXYL is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Levoxyl

A generic version of LEVOXYL was approved as levothyroxine sodium by MYLAN on June 5^th, 2002.

Summary for LEVOXYL

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	114
Clinical Trials:	1
Patent Applications:	6,897
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for LEVOXYL
Drug Sales Revenues:	Drug sales revenues for LEVOXYL
What excipients (inactive ingredients) are in LEVOXYL?	LEVOXYL excipients list
DailyMed Link:	LEVOXYL at DailyMed

See drug prices for LEVOXYL

See drug sales revenues for LEVOXYL

Recent Clinical Trials for LEVOXYL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Children's Hospital of Philadelphia	N/A
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	N/A

See all LEVOXYL clinical trials

Pharmacology for LEVOXYL

Drug Class

l-Thyroxine

Anatomical Therapeutic Chemical (ATC) Classes for LEVOXYL

H03AA	Thyroid hormones
H03A	THYROID PREPARATIONS
H03	THYROID THERAPY
H	Systemic hormonal preparations, excluding sex hormones and insulins

US Patents and Regulatory Information for LEVOXYL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
King Pharms	LEVOXYL	levothyroxine sodium	TABLET;ORAL	021301-001	May 25, 2001	AB1,AB3	RX	Yes	No
King Pharms	LEVOXYL	levothyroxine sodium	TABLET;ORAL	021301-007	May 25, 2001	AB1,AB3	RX	Yes	No
King Pharms	LEVOXYL	levothyroxine sodium	TABLET;ORAL	021301-004	May 25, 2001	AB1,AB3	RX	Yes	No
King Pharms	LEVOXYL	levothyroxine sodium	TABLET;ORAL	021301-012	May 25, 2001		DISCN	Yes	No
King Pharms	LEVOXYL	levothyroxine sodium	TABLET;ORAL	021301-008	May 25, 2001	AB1,AB3	RX	Yes	No

Expired US Patents for LEVOXYL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
King Pharms	LEVOXYL	levothyroxine sodium	TABLET;ORAL	021301-011	May 25, 2001
King Pharms	LEVOXYL	levothyroxine sodium	TABLET;ORAL	021301-008	May 25, 2001
King Pharms	LEVOXYL	levothyroxine sodium	TABLET;ORAL	021301-003	May 25, 2001
King Pharms	LEVOXYL	levothyroxine sodium	TABLET;ORAL	021301-001	May 25, 2001
King Pharms	LEVOXYL	levothyroxine sodium	TABLET;ORAL	021301-010	May 25, 2001

International Patents for LEVOXYL

See the table below for patents covering LEVOXYL around the world.

Country	Patent Number	Title	Estimated Expiration
World Intellectual Property Organization (WIPO)	02067854
Japan	2004525109
Norway	20033636
Australia	2002240394
Australia	2002332507